MentionFox
Home › Who owns › AMICUS THERAPEUTICS, INC.
Owners, funding and legal record

Who owns AMICUS THERAPEUTICS, INC.? Owners, funding and legal record

The most recent 5%+ ownership report on AMICUS THERAPEUTICS, INC. names Barclays PLC holding 5.65% (Schedule 13G, filed 2026-05-14).

About to sign with, pay or invest in AMICUS THERAPEUTICS, INC.? See the free Snapshot first.

Free to see. No signup.

Before you sign or pay

Who is behind it

AMICUS THERAPEUTICS, INC.: incorporated in Delaware; business address in Princeton, New Jersey; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-12).

Officers and directors, each with the role and the filing that names them:

ReportHolderShare
Schedule 13G/A, 2026-08-12The Goldman Sachs Group, Inc.0%
Schedule 13G, 2026-05-14Barclays PLC5.65%
Schedule 13G, 2026-05-11The Goldman Sachs Group, Inc.5.3%
Schedule 13G, 2026-05-07Ubs Group Ag5.5%
Schedule 13G, 2026-05-01Glazer Capital, LLC0%
Schedule 13G, 2026-04-29Vanguard Capital Management5.2%
Schedule 13G/A, 2026-03-26The Vanguard Group0%
Schedule 13G/A, 2026-02-10Wellington Management Group LLP0.4%

Money raised

FiledSoldOffered
Form D, 2023-10-16$30M$30M

Acquisitions reported on Form 8-K, Item 2.01: acquired by BioMarin Pharmaceutical Inc. (2026-04-27).

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/amicus-therapeutics
Last updated 2026-10-18
Who owns AMICUS THERAPEUTICS, INC.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/amicus-therapeutics